STOCK TITAN

Amanat Acquisition: Great Point reports 6.41% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Amanat Acquisition Corp. (AMAN) is named in an amended Schedule 13G reporting that Great Point Partners, LLC, its Senior Managing Member Dr. Jeffrey R. Jay, M.D., and its Managing Director Ms. Lillian Nordahl each report shared beneficial ownership of the same 500,000 Class A ordinary shares, or 6.41%, for the September 30, 2026 event date. They report shared voting and dispositive power over those shares.

Biomedical Value Fund, L.P. is the record holder of 330,000 shares, and Biomedical Offshore Value Fund, Ltd. is the record holder of 170,000. Great Point is investment manager of both funds; Dr. Jay and Ms. Nordahl may be deemed beneficial owners through their voting and investment power. The reporting persons disclaim beneficial ownership except to the extent of their respective pecuniary interests. The 6.41% is based on 7,800,000 shares outstanding, as reported by Amanat in its Form 10-Q filed August 13, 2026.

Shared beneficial ownership 500,000 shares The same block is reported by each of the three reporting persons.
Percent of class 6.41% Based on 7,800,000 shares outstanding reported in Amanat's Form 10-Q filed August 13, 2026.
Shares outstanding 7,800,000 shares Reported by Amanat in its Form 10-Q filed August 13, 2026.
Biomedical Value Fund, L.P. record holding 330,000 shares Shares reported as held of record by the fund.
Biomedical Offshore Value Fund, Ltd. record holding 170,000 shares Shares reported as held of record by the fund.
beneficial ownership financial
"Amount beneficially owned: 500,000"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Shared Voting Power financial
"Shared Voting Power 500,000.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power financial
"Shared Dispositive Power 500,000.00"
investment manager financial
"Great Point is the investment manager of BVF"
pecuniary interests financial
"except to the extent of their respective pecuniary interests"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AMAN shares do the reporting persons beneficially own?

Great Point Partners, LLC, its Senior Managing Member Dr. Jeffrey R. Jay, M.D., and its Managing Director Ms. Lillian Nordahl each report shared beneficial ownership of 500,000 Class A ordinary shares, or 6.41%. Their reports describe shared voting and dispositive power over the same block.

Which funds hold the AMAN shares reported by Great Point?

Biomedical Value Fund, L.P. is the record holder of 330,000 shares, and Biomedical Offshore Value Fund, Ltd. is the record holder of 170,000 shares. Great Point Partners, LLC is the investment manager of both funds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





G0375M101

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Great Point Partners, LLC
Signature:/s/ Dr. Jeffrey R. Jay, M.D
Name/Title:Dr. Jeffrey R. Jay, M.D - Senior Managing Member
Date:11/16/2026
Dr. Jeffrey R. Jay, M.D.
Signature:/s/ Dr. Jeffrey R. Jay, M.D
Name/Title:Dr. Jeffrey R. Jay, M.D
Date:11/16/2026
Ms. Lillian Nordahl
Signature:/s/ Ms. Lillian Nordahl
Name/Title:Ms. Lillian Nordahl
Date:11/16/2026
Exhibit Information

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned hereby agree as follows: (i) Each of them is individually eligible to use the SCHEDULE 13G to which this Exhibit is attached, and such SCHEDULE 13G is filed on behalf of each of them; and (ii) Each of them is responsible for the timely filing of such SCHEDULE 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. Dated: November 16, 2026 Great Point Partners, LLC By: /s/ Dr. Jeffrey R. Jay, M.D. Dr. Jeffrey R. Jay, M.D., as Senior Managing Member Dr. Jeffrey R. Jay, M.D. By: /s/ Dr. Jeffrey R. Jay, M.D. Dr. Jeffrey R. Jay, M.D. Ms. Lillian Nordahl By: /s/ Ms. Lillian Nordahl Ms. Lillian Nordahl

Keep reading